The class now includes three types: GLP-1 agonists: Activate the GLP-1 receptor only (semaglutide, liraglutide, exenatide, dulaglutide, lixisenatide, orforglipron) Dual GLP-1/GIP agonists: Activate both GLP-1 and GIP receptors (tirzepatide) Triple agonists (investigational): Activate GLP-1, GIP, and glucagon receptors (retatrutide, in Phase 3 trials) GLP-1 Medications Compared: Full Comparison Chart Here's every GLP-1 medication currently FDA-approved, with the data you actually need to compare them side by side
: -
Studies suggest that the amino acid sequence in GHK-Cu may have anti-RCS potential against radicals such as 4-hydroxynoneal, acrolein, malondialdehyde, and others
Hypoxia-reprogramed megamitochondrion contacts and engulfs lysosome to mediate mitochondrial self-digestion
It helps reduce oxidative stress, which is one of the main reasons behind dullness and uneven tone